Source: iQoncept / Shutterstock
Fractyl Health (NASDAQ:GUTS) emerged victorious with their first-quarter performance review for 2024.
- Fractyl Health delivered earnings per share of -17 cents, trumping analyst predictions set at -30 cents.
- The firm clocked in revenue figures of $33,000.
The InvestorPlace Earnings initiative utilizes insights from TradeSmith to streamline coverage of quarterly financial updates. Crystallizing essential details such as earnings per share and revenue, it also scrutinizes a company’s alignment with analyst forecasts. These articles are released autonomously, enabling the rapid dissemination of the latest financial data to our audience. For any corrections or issues, please reach out to us via editor@investorplace.com.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/guts-stock-earnings-fractyl-health-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC
